Report cover image

North America Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949628

Description

The North America Small Molecule Drug Discovery Market is projected to grow significantly, reaching approximately US$ 56,040.1 million by 2031, up from US$ 26,303.5 million in 2023, reflecting a compound annual growth rate (CAGR) of 10.0% from 2023 to 2031.

Executive Summary and Market Analysis

The small molecule drug discovery market in North America is experiencing steady growth driven by several key factors. A primary catalyst is the increasing focus of pharmaceutical and biotechnology companies on robust research and development initiatives aimed at discovering innovative and effective small molecule drugs. The market is benefiting from substantial investments in the pharmaceutical sector, which are enhancing advanced drug discovery technologies and expediting product development. Additionally, the rising incidence of chronic diseases, particularly cancer, is fueling the demand for new treatment options, further propelling market growth. The United States is at the forefront, supported by a strong research infrastructure, the presence of major global pharmaceutical firms, and a favorable regulatory environment. Canada and Mexico are also showing promising developments, with improving healthcare systems and government initiatives to promote biomedical research. Collectively, these factors are expected to drive the North American small molecule drug discovery market in the coming years.

Strategic Insights

Market Segmentation Analysis
  • By Therapeutic Area: The market is categorized into Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas, with Oncology holding the largest market share in 2023.
  • By Process or Phase: The market is divided into Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development, where Lead Generation and Refinement dominated in 2023.
Market Outlook

The integration of artificial intelligence (AI) and related technologies is making drug discovery more cost-effective and efficient. AI facilitates innovative data collection and management methods, reducing reliance on manual processes. Leading biopharmaceutical companies are leveraging AI platforms to accelerate drug discovery. For example, Pfizer utilizes IBM Watson to enhance its search for immuno-oncology drugs, while Sanofi has partnered with Exscientia to discover therapies for metabolic diseases. Genentech employs an AI system from GNS Healthcare to explore cancer treatments. AI tools are increasingly used for screening and identifying compounds, as well as minimizing potential drug interactions.

The rapid adoption of AI in healthcare has led many pharmaceutical companies to form partnerships with AI firms to identify drug targets and design new drugs. Notable collaborations include Merck's partnership with BenevolentAI and Exscientia in 2023, aimed at enhancing AI-driven design and discovery capabilities. Additionally, Evommune Inc. partnered with Accutar Biotechnology Inc. to discover novel small molecule drug candidates for chronic inflammatory diseases, leveraging Accutar's AI platform and Evommune's expertise.

Country Insights

The North American market is segmented by country into the United States, Canada, and Mexico, with the United States holding the largest market share in 2023. The growth in the US market is primarily driven by the increasing prevalence of chronic diseases such as cardiovascular diseases and cancer. According to the American Cancer Society, approximately 2 million new cancer cases are expected in 2024, with around 611,000 deaths projected. This scenario is prompting significant investments in research and development for novel drug molecules. A robust drug pipeline and increasing approvals for small molecule drugs are anticipated to further stimulate market growth, alongside heightened awareness of advanced therapeutic options.

Company Profiles

Key players in the North America Small Molecule Drug Discovery Market include GSK Plc, Charles River Laboratories International Inc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co, Merck KGaA, ICON Plc, Revvity Inc, Danaher Corp, and Thermo Fisher Scientific Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. North America Small Molecule Drug Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Small Molecule Drug Discovery Market - North America Market Analysis
5.1 North America Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
5.2 North America Small Molecule Drug Discovery Market Forecast and Analysis
6. North America Small Molecule Drug Discovery Market Revenue Analysis - by Therapeutic Area
6.1 Oncology
6.1.1 Overview
6.1.2 Oncology: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Central Nervous System
6.2.1 Overview
6.2.2 Central Nervous System: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Cardiovascular
6.3.1 Overview
6.3.2 Cardiovascular: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Respiratory
6.4.1 Overview
6.4.2 Respiratory: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Orthopedics
6.5.1 Overview
6.5.2 Orthopedics: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.6 Immunology
6.6.1 Overview
6.6.2 Immunology: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.7 Rare Diseases
6.6.1 Overview
6.6.2 Rare Diseases: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.8 Other Therapeutic Areas
6.8.1 Overview
6.8.2 Other Therapeutic Areas: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. North America Small Molecule Drug Discovery Market Revenue Analysis - by Process Or Phase
7.1 Target Discovery
7.1.1 Overview
7.1.2 Target Discovery: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Target Validation
7.2.1 Overview
7.2.2 Target Validation: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Lead Generation and Refinement
7.3.1 Overview
7.3.2 Lead Generation and Refinement: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Preclinical Development
7.4.1 Overview
7.4.2 Preclinical Development: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. North America Small Molecule Drug Discovery Market - Country Analysis
8.1 North America
8.1.1 North America Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.1.1 North America Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.2.2 United States: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 United States: North America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.1.2.2.2 United States: North America Small Molecule Drug Discovery Market Share - by Process Or Phase
8.2.3.3 Canada: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 Canada: North America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.2.3.3.2 Canada: North America Small Molecule Drug Discovery Market Share - by Process Or Phase
8.3.4.4 Mexico: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 Mexico: North America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.3.4.4.2 Mexico: North America Small Molecule Drug Discovery Market Share - by Process Or Phase
9 Industry Landscape
9.1 Overview
10 COMPANY PROFILES
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Charles River Laboratories International Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Bristol-Myers Squibb Co
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Merck KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 ICON Plc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Revvity Inc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Danaher Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Oncodesign Services
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Small Molecule Drug Discovery Market Segmentation
Table 3. North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 5. North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 6. North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. United States: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 8. United States: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 9. Canada: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 10. Canada: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 11. Mexico: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 12. Mexico: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 13. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. North America Small Molecule Drug Discovery Market Segmentation - Country
Figure 4. North America Small Molecule Drug Discovery Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
Figure 7. North America Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area, 2023 and 2031
Figure 8. Oncology: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Central Nervous System: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardiovascular: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Respiratory: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Orthopedics: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunology: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Rare Diseases: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Other Therapeutic Areas: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. North America Small Molecule Drug Discovery Market Share (%) - by Process Or Phase, 2023 and 2031
Figure 17. Target Discovery: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Target Validation: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Lead Generation and Refinement: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Preclinical Development: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. North America Small Molecule Drug Discovery Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 22. United States: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Canada: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Mexico: North America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us